This study aimed to examine the current situation of anti-cancer drug shortages in Pakistan, namely its determinants, impacts, adopted mitigation strategies, and proposed solutions. Qualitative semi-structured, in-depth interviews were conducted with 25 pharmacists in oncology hospitals in Pakistan from August to October 2021. Data were collected in person and online, recorded, and subjected to inductive thematic analysis after being transcribed verbatim. Most participants experienced anti-cancer drug shortages that increased during the pandemic. Etoposide, paclitaxel, vincristine, dacarbazine, and methotrexate were frequently short. Important causes included the compromised role of regulatory authorities, lack of local production, and inventory mismanagement. The impacts were delayed/suboptimal treatment and out-of-pocket costs for patients, patients’ prioritization, increased workload, negative work environment, and patients’ trust issues for pharmacists. The participants proposed that a cautious regulator’s role is needed to revise policies for all stakeholders and support all stakeholders financially at their level to increase access to these medicines. Based on the outcomes, it is clear that anti-cancer medicine shortages are a current issue in Pakistan. Governmental authorities need to play a role in revising policies for all levels of the drug supply chain and promoting local production of these drugs. Stakeholders should also collaborate and manage inventory.
15 July 2022 in Journal of Oncology Pharmacy Practice
Objective: Anti-cancer medicine shortages are advancing challenges for patients and hospitals. This study aims to evaluate anti-cancer and supportive medicine shortages in a tertiary hospital in Pakistan and propose solutions. Method: A retrospective observational research was performed in a tertiary care hospital in Pakistan from 2016 to 2020. Data was retrieved from the hospital database using a questionnaire regarding short medicines’ generic name, brand, dosage, source, total source, frequency, causes, impact, management, and analyzed by Microsoft Excel 2013. Results: Between January 2016 and December 2020, 43 individual medicine shortages were observed, with an average of 8.6 shortages per year. There were shortages of 22 medicines, including 8 anti-cancer (36.4%) and 14 supportive agents (63.6%). Total shortage days were 27,100, with an average of 1232 days (SD 757) per medicine. Supportive medicines’ shortages were frequent, but oncology agents’ shortages were constant. The most affected dosage form was injection. Cardiovascular drugs and alkylating agents were the most affected class in supportive and anti-cancer medicines, respectively. The use of “alternative medicine” and “patient needs based importation” were the most common mitigation strategies. Conclusion: Shortages of oncology medicines are challenging in Pakistan. The most prominent causes are the lack of updated governmental regulations, registration, and import issues. The tertiary care hospital has very few sources of supply, so it imports these drugs on a need basis to manage the shortages. But it is still concerning because of the huge financial burden on patients and institutions due to expensive import, and therapy become delayed as the import process takes time. Moreover, the most affected drug class was alkylating agents, and dosage was both injectable and oral medicines.
2 April 2023 in Journal of Oncology Pharmacy Practice
Objective: The lack of anticancer drugs for curative and supportive purposes is the critical reason for the low survival rate in low-and-middle-income countries. This study aims to analyze whether the National Essential Medicines List (NEML) and Registered Essential Medicines List (REML) are in concordance with the World Health Organization (WHO) Essential Medicines List (EML) and whether the formularies prevalent in the country are parallel to each other and to the NEML. Method: An observational study design was used in which antineoplastic drugs from the 2021 NEML and REML were compared with 2021 WHO EML to evaluate their availability in Pakistan. Market access was determined. Moreover, the formularies of six different hospital types were compared with each other and with the NEML, and REML to estimate the availability within hospitals. Results: There were 66 anticancer drugs in 2021 WHO EML and all were found in Pakistan's 2021 NEML but only 48 drugs (73%) were found in the REML. Hydroxycarbamide and dasatinib were two registered drugs absent in all hospitals’ formularies. The market access for anticancer medicines was 73% (48 of 66). Semigovernment hospital (86%) has the highest availability, followed by the government hospital (80%). All the hospitals have unregistered drugs including bortezomib, lenalidomide, and mesna. Conclusion: Pakistan's NEML adopts WHO EML abruptly but all medicines are not registered. The hospitals are trying their best to increase availability but optimum drug regulations to revise NEML based on the country's requirements and emphasizing registration of anticancer medicines are needed to improve the country's availability of antineoplastic agents.
29 June 2026 in Journal of Oncology Pharmacy Practice
Objectives: To evaluate adolescents’ knowledge, attitude, and risk perceptions regarding e-cigarette usage and examine the associations and differences across various socio-demographic characteristics. Methods: A cross-sectional study was conducted in two government secondary schools in Johor. A total of 391 respondents were enrolled conveniently using a pre-validated questionnaire. The data were analysed using SPSS descriptive and inferential statistics. Results: Most participants demonstrated a moderate level of knowledge regarding e-cigarettes (77.5 %), achieving an average score of 3.82 (±0.89). A significant portion of the respondents were female (56.3 %) and Chinese (57.5 %), predominantly aged between 16 and 17 years (53.7 %). Presently, 11.5 % of the participants reported using e-cigarettes, while 6.6 % reported using traditional tobacco cigarettes. Notably, 12.3 % of adolescents correctly identified nicotine as a common component in e-cigarettes, highlighting its addictive nature. Furthermore, significant association and differences were observed between e-cigarette usage and a positive attitude towards them (86.7 %, p<0.001), as well as the perception of reduced health risks associated with e-cigarette consumption (9.11 ± 2.68, p<0.001). Adolescents who were susceptible to e-cigarette use were more inclined to support their usage (63.1 %, p<0.001) and perceived fewer health consequences (6.91 + 3.12, p=0.019) in comparison to those who were not susceptible. Conclusions: E-cigarette users exhibited a moderate level of understanding along with a positive stance towards e-cigarettes, viewing them as less risky compared to non-e-cigarette users. As a result, collaborative endeavours are essential to enhance adolescent knowledge about e-cigarettes via community outreach initiatives. Consequently, all governing bodies must explore effective strategies to tackle this issue by implementing strict legislation.